ICADICAD INC

Nasdaq icadmed.com


$ 1.39 $ 0.00 (0 %)    

Wednesday, 11-Sep-2024 15:59:44 EDT
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 1.39
$ 1.39 x 600
$ 1.40 x 1,180
-- - --
$ 1.18 - $ 2.65
45,189
na
36.89M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-11-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-30-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-24-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-11-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-13-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 icad-q2-2024-gaap-eps-007-inline-sales-500m-beat-442m-estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The company report...

 icad-and-windsong-radiology-ink-strategic-commercial-agreement-to-implement-ai-powered-mammography

iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced a strategi...

 icad-q1-adj-005-beats-006-estimate-sales-495m-beat-444m-estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67...

 icad-q4-earnings-insights
icad: Q4 Earnings Insights
03/12/2024 20:10:17

 icad-q4-2023-adj-eps-002-beats-005-estimate-sales-4741m-beat-4300m-estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by 60 pe...

 earnings-scheduled-for-march-12-2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

 earnings-outlook-for-icad
Earnings Outlook For icad
03/11/2024 17:01:01

 icad-highlights-clinical-data-demonstrating-ability-to-reduce-breast-interval-cancer-rates-and-decrease-recall-rates-at-ecr-2024-showcases-additional-platform-offerings

Clinical evidence demonstrates ProFound Detection's AI may help reduce breast interval cancer (IC) rates and decrease recal...

 icads-profound-ai-can-predict-1-2-year-risk-for-breast-cancer-and-reveal-insights-for-heart-disease

New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite...

 recap-icad-q3-earnings
Recap: icad Q3 Earnings
11/13/2023 21:10:17

 icad-q3-2023-gaap-eps-005-beats-008-estimate-sales-407m-miss-627m-estimate

icad (NASDAQ:ICAD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 ...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION